Heart Rhythm
Volume 2, Issue 10 , Pages 1116-1121, October 2005

Direct imaging of transvenous radiofrequency cardiac ablation using a steerable fiberoptic infrared endoscope

  • Bradley P. Knight, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, University of Chicago, Chicago, Illinois
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Bradley P. Knight, University of Chicago Hospitals, Center for Advance Medicine, MC 9024, 5758 South Maryland Avenue, Chicago, Illinois 60637
  • ,
  • Martin C. Burke, DO

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, University of Chicago, Chicago, Illinois
  • ,
  • Thomas E. Hong, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, University of Chicago, Chicago, Illinois
  • ,
  • Al McAuley, BS

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, University of Chicago, Chicago, Illinois
  • ,
  • David Amundson, MS

      Affiliations

    • Cardio-Optics Inc., Boulder, Colorado
  • ,
  • John Hanlin, MS

      Affiliations

    • Cardio-Optics Inc., Boulder, Colorado
  • ,
  • Larry Blankenship, BS

      Affiliations

    • Cardio-Optics Inc., Boulder, Colorado
  • ,
  • T. Bruce Ferguson Jr., MD

      Affiliations

    • Department of Surgery, Louisiana State University, New Orleans, Louisiana
  • ,
  • Saman Nazarian, MD

      Affiliations

    • Johns Hopkins University, Baltimore, Maryland
  • ,
  • Ronald D. Berger, MD, PhD

      Affiliations

    • Johns Hopkins University, Baltimore, Maryland

Received 25 May 2005; accepted 12 July 2005. published online 29 July 2005.

Background

Direct imaging through blood has been achieved in vivo using fiberoptics and infrared wavelength technology.

Objectives

The purpose of this study was to determine the feasibility of using a percutaneous, steerable, fiberoptic infrared endoscope to identify and characterize the electrode–tissue interface during transvenous cardiac ablation.

Methods

Infrared endoscopy was performed during 24 catheter ablation attempts in 10 mongrel dogs. Infrared imaging was performed through a transparent dome located at the tip of a 7Fr steerable endoscope using an imaging wavelength of 1,620 nm. Radiofrequency ablation was performed using a 4-mm-tip electrode catheter. Attempts were made to identify the electrode–endocardial interface at each ablation site and to characterize any signal changes during ablation.

Results

The electrode–tissue interface could be identified at 19 of the 24 ablation sites. Changes at the electrode–tissue interface were observed during ablation at 14 sites, which included a gradual increase in the tissue signal intensity at 12 sites. Small lucencies near the ablation electrode were observed at six sites. There was no interference during energy delivery. Endocardial features identified by endoscopy correlated with the postmortem appearance.

Conclusion

Direct imaging of intracardiac structures and the electrode–tissue interface can be achieved through blood during transvenous catheter ablation with infrared endoscopy using a steerable, fiberoptic, infrared endoscopic catheter. Ablation lesion formation can be seen as a gradual increase in signal intensity. Fiberoptic infrared endoscopy appears to be a promising new tool for guiding catheter ablation.

Keywords:  Imaging , Ablation , Radiofrequency , Infrared , Endoscope

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by a grant from CardioOptics, Inc., Boulder, Colorado. Drs. Knight, Ferguson, and Berger serve as medical advisors for CardioOptics Inc. Dr. Knight was provided CardioOptics stock options for his role as medical advisor. David Amundson, John Hanlin, and Larry Blankenship are employees of CardioOptics Inc.

PII: S1547-5271(05)01871-0

doi:10.1016/j.hrthm.2005.07.010

Heart Rhythm
Volume 2, Issue 10 , Pages 1116-1121, October 2005